Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Daliani

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology|March 1, 1997
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapyM A Dimopoulos, D Daliani, W Pugh, et al.
The Journal of Urology|May 1, 1995
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancerD D Daliani, P D Eisenberg, J Weems, et al.
Andrologia|August 14, 2015
Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disordersK Dimitropoulos, A Karatzas, C Papandreou, et al.
Onkologie|September 15, 2010
Nonbacterial thrombotic (marantic) endocarditis in a patient with colorectal cancerPanagiotis J Vlachostergios, Danai D Daliani, Vassilis Dimopoulos, et al.
Anti-Cancer Drugs|August 1, 1995
5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer: a pilot studyN Tsavaris, K Tentas, C Bacoyiannis, et al.
Anticancer Research|July 18, 2008
Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancerAlexandros Daponte, Eva Kostopoulou, C N Papandreou, et al.
Cancer|August 10, 2000
A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinomaL Pagliaro, D Daliani, R Amato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancerC J Logothetis, K K Wu, L D Finn, et al.
Oncology|July 1, 1995
Efficacy of ondansetron treatment with different timing schedules: a randomized double-blind studyN Tsavaris, N Mylonakis, C Bacoyiannis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancerD Bafaloukos, G Samonis, A Klinaki, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|March 1, 1997
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapyM A Dimopoulos, D Daliani, W Pugh, et al.
The Journal of Urology|May 1, 1995
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancerD D Daliani, P D Eisenberg, J Weems, et al.
Andrologia|August 14, 2015
Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disordersK Dimitropoulos, A Karatzas, C Papandreou, et al.
Onkologie|September 15, 2010
Nonbacterial thrombotic (marantic) endocarditis in a patient with colorectal cancerPanagiotis J Vlachostergios, Danai D Daliani, Vassilis Dimopoulos, et al.
Anti-Cancer Drugs|August 1, 1995
5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer: a pilot studyN Tsavaris, K Tentas, C Bacoyiannis, et al.
Anticancer Research|July 18, 2008
Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancerAlexandros Daponte, Eva Kostopoulou, C N Papandreou, et al.
Cancer|August 10, 2000
A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinomaL Pagliaro, D Daliani, R Amato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancerC J Logothetis, K K Wu, L D Finn, et al.
Oncology|July 1, 1995
Efficacy of ondansetron treatment with different timing schedules: a randomized double-blind studyN Tsavaris, N Mylonakis, C Bacoyiannis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancerD Bafaloukos, G Samonis, A Klinaki, et al.
Pageof 4